Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC ; day:19 ; month:9 ; year:2020 ; pages:1-11
European journal of nuclear medicine and molecular imaging ; (19.9.2020), 1-11
- Creator
-
Kramer, Vasko
Fernández, René
Lehnert, Wencke
Jiménez-Franco, Luis David
Soza-Ried, Cristian
Eppard, Elisabeth
Ceballos, Matias
Meckel, Marian
Benešová, Martina
Umbricht, Christoph A.
Kluge, Andreas
Schibli, Roger
Zhernosekov, Konstantin
Amaral, Horacio
Müller, Cristina
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-020-05022-3
- URN
-
urn:nbn:de:101:1-2020110815534132752095
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kramer, Vasko
- Fernández, René
- Lehnert, Wencke
- Jiménez-Franco, Luis David
- Soza-Ried, Cristian
- Eppard, Elisabeth
- Ceballos, Matias
- Meckel, Marian
- Benešová, Martina
- Umbricht, Christoph A.
- Kluge, Andreas
- Schibli, Roger
- Zhernosekov, Konstantin
- Amaral, Horacio
- Müller, Cristina
- SpringerLink (Online service)
Other Objects (12)
![Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies](/assets/placeholder/searchResultMediaUnknown.png)
Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Preclinical biodistribution and dosimetry and human biodistribution comparing 18F-rhPSMA-7 and single isomer 18F-rhPSMA-7.3
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
177Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model
Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy
Physiological biodistribution on Ga68-PSMA PET/CT and the factors effecting biodistribution
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison [Abstract]
Towards personalized internal radionuclide therapies with 90Y SIRT and 177Lu-PSMA: an investigation of 3D image based dosimetry
Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Preclinical biodistribution and dosimetry and human biodistribution comparing 18F-rhPSMA-7 and single isomer 18F-rhPSMA-7.3
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
177Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model
Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy
Physiological biodistribution on Ga68-PSMA PET/CT and the factors effecting biodistribution
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison [Abstract]
Towards personalized internal radionuclide therapies with 90Y SIRT and 177Lu-PSMA: an investigation of 3D image based dosimetry
Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Preclinical biodistribution and dosimetry and human biodistribution comparing 18F-rhPSMA-7 and single isomer 18F-rhPSMA-7.3
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
177Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model
Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy
Physiological biodistribution on Ga68-PSMA PET/CT and the factors effecting biodistribution
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients
Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison [Abstract]